Delivery Order SPE2DR25D3005-SPE2DR26FP8HE
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,968.71 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count packages) on December 29, 2025, with completion expected by December 30, 2025. This non-competitive, firm fixed-price delivery order represents a pharmaceutical supply fulfillment under the company's existing contract vehicle with the federal government. The place of performance is listed as Conshohocken, Pennsylvania, which serves as...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count) with a ceiling value of $15,178.69. This is a firm fixed-price, non-set-aside delivery order awarded on May 5, 2025, with an ultimate completion date of May 6, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...
- The Defense Logistics Agency awarded a $36,336.21 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 4MG tablets (30-count supply) on December 17, 2025, with an ultimate completion date of January 15, 2026. The contract utilizes no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $6,314.29 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units). This firm fixed-price, competitively awarded delivery order was issued on December 30, 2025, with an ultimate completion date of December 31, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count) under a firm fixed-price contract valued at $8,420.18. The award, issued on December 19, 2025, with an ultimate completion date of December 22, 2025, represents a competitively awarded, non-set-aside transaction. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this order from its corporate office location. This delivery...
- The Defense Logistics Agency awarded a $27,358.58 delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units. This competitive award, executed on December 5, 2025, represents a firm fixed price delivery order with a completion date of December 8, 2025. The order will be fulfilled at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $11,237.48 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count package). This is a firm fixed price, non-set-aside competitive contract with an ultimate completion date of December 18, 2025, to be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of $8,962.67 under a firm fixed price structure, with an ultimate completion date of August 20, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $11,535.36 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of December 16, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal vendor specializing in medical procurement for military and veteran healthcare systems. The delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units) under a firm fixed-price contract valued at $6,713.22. The contract was competitively awarded without set-aside designation and is scheduled for completion by November 21, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office location. This delivery order represents a child contract...
- SPE2DR25D3005Indefinite Delivery Contract
- SPE2DR25D3005-SPE2DR26FP8HEDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count) with a ceiling value of $31,377.80. This is a firm fixed-price delivery order with no set-aside designation, issued on December 31, 2025, with an ultimate completion date of January 2, 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 through December 2026 that enables the company to supply medications and medical supplies to support military healthcare programs globally. As a critical vendor for federal medical procurement, AmerisourceBergen Drug Corp has demonstrated extensive capability in fulfilling pharmaceutical supply requirements for defense and veteran healthcare systems through competitive procurement processes. Ondansetron is an antiemetic medication commonly used in military and federal healthcare settings for nausea and vomiting management. The company's federal contract portfolio reflects its role as a primary pharmaceutical distributor for the Defense Health Agency and other government healthcare systems, with delivery orders consistently executed under firm fixed-price arrangements across multiple therapeutic domains and product categories.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $31.4k | 12/30/25 |